Thorsten Waloschek: Addressing Risks in Pregnancies with Sclerosis
Thorsten Waloschek, CEO of NeoPredics AG, shared a post on LinkedIn:
“A new study from The Lancet Rheumatology caught my attention this week.
It examines pregnancy outcomes in women with systemic sclerosis and highlights a reality we still need to confront. Even with a high live birth rate, the risks for mothers remain significantly elevated, particularly when it comes to preeclampsia, placental insufficiency, preterm birth, and severe postpartum complications.
Pregnancy places an extraordinary cardiovascular demand on the body, and for women with underlying autoimmune or vascular conditions, those risks can rise sharply. What concerns me most is that nearly 40 percent of pregnancies in the study showed worsening disease during pregnancy or within the first year postpartum. It reinforces something many in maternal health already know: we still lack effective, accessible tools for early risk detection.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 16, 2025, 15:03Always a Great Pleasure Returning to St. Jude Children’s Research Hospital – Gevorg Tamamyan
-
Dec 16, 2025, 14:45Chemical Pollution’s Impact on Male Reproductive Health – Cesar Fertility
-
Dec 16, 2025, 14:27Discover This Month’s Must-Read Articles – Fertility and Sterility
-
Dec 16, 2025, 13:20New Diagnostic Tools for Infertility Explored in Latest Review – Reproductive BioMedicine Online
-
Dec 15, 2025, 15:33Severe Postpartum Hemorrhage: Advances in Care Techniques – AGOF Asso Gynéco Obs en Formation
-
Dec 15, 2025, 15:27Silvia Alvarez: Key Findings on Egg Freezing Impact
-
Dec 14, 2025, 16:45Navigating Women’s Health Across Life Stages at SIGO – AOGOI
-
Dec 14, 2025, 16:38Steven Palter: The Role of Nutrition in Managing Infertility Explored
-
Dec 14, 2025, 16:19Impact of Preconception Metabolic Health on Fertility – Carrot